Mariléna Gryparis

Mariléna is counsel in Goodwin’s “Capital markets” teams in the Life Sciences and Technology groups.

She advises issuers and banks on a wide range of financing transactions, in particular IPOs (on Euronext Paris, Euronext Growth and Nasdaq), capital increases (through public offerings or private placements), equity-linked issuances and bond issues (EMTN programme updates, drawdowns, standalone issues, EuroPP) as well as the issue of hybrid securities. She also advises listed companies on corporate law and securities law matters, mainly relating to governance.

Prior to joining Goodwin in 2024, she was counsel at Gide.

Mariléna’s recent work includes advising:

• A listed biopharmaceutical company, in an immediate financing in the form of ordinary shares and warrants, of €94.1 million and up to €348 million.*
• A pool of international investment banks on the capital increase by Sensorion for a total gross amount of €50.5 million.*
• A French bank and a Dutch wealth management firm on the capital increase by Argan for a total gross amount of €150 million.*
• Bryan Garnier & Co, a French bank, Natixis and Gilbert Dupont on the capital increase by Waga Energy for a total gross amount of €52 million.*
• A pool of international investment banks on the $235.8 million initial public offering (IPO) on the Nasdaq Global Market of Abivax by way of a capital increase of approximately €223.3 million.*
• A pool of American investment banks on the capital increase by Nanobiotix reserved to category of investors, for an estimated total gross amount of USD 33.6 million, through an offering of American Depositary Shares (ADS) in the United States and a private placement of ordinary shares in Europe.*
• A listed biopharmaceutical company on a financing of approximately EUR 35.7 million consisting of a EUR 30.6 million reserved capital increase and a EUR 5.1 million issuance of royalty certificates (2023)
• A pool of American investment banks, on the USD 194 million PIPE deal of DBV Technologies, a dual listed company, through the offer of 32,855,669 ordinary shares and of 28,276,331 pre-funded warrants.*
• Air France-KLM on its capital increase with preferential subscription rights of approximately EUR 2.256 billion.*
• Bank Degroof Petercam SA/NV and a European investment bank on Carmat's share capital increases reserved to specialized and strategic investors in Europe and the United States and to retail investors via the PrimaryBid platform, for a total amount of approximately EUR 40.5 million.*
• Antin Infrastructure Partners on its initial public offering (IPO) of €632.5 million on the regulated market of Euronext Paris.*
• A pool of investment banks on the initial public offering (IPO) of Valneva on the Nasdaq Global Select Market, through a capital increase reserved to a category of investors, for an estimated total gross amount of USD 107.6 million.*
• A pool of banks on the capital increase of Air France KLM in an amount of approximately EUR 1 billion through a public offering with a priority subscription period.*
• A pool of international investment banks, on the sale of 12 million shares in Alstom held by Bouygues through a placement to qualified investors by way of an accelerated bookbuilding offering for an amount of EUR 500 million.*
• A listed biopharmaceutical company on its initial public offering (IPO) on the Nasdaq Global Market by way of a capital increase for USD 107.7 million.*
• Bank syndicate on the double issuance by Société du Grand Paris of green bonds in an amount of EUR 6 billion.*
• A pool of European investment banks on the issuance of bonds convertible into new shares and/or exchangeable for existing shares (OCEANE) by Air France-KLM for a total amount of €500 million.*
• QUARTUS on its first issuance of bonds under the EuroPP format for EUR 75 million.*
• Erytech Pharma on its initial public offering on the Nasdaq, through a reserved capital increase to American and European specialist investors for a total aggregate amount of USD 144 million.*
• Lysogene on its initial public offering, by way of a capital increase of €22.6 million on Euronext Paris.*
• BIM on its first issuance of bonds under the EuroPP format for EUR 85 million.*

*Denotes experience prior to joining Goodwin.

Named "Ones to watch" in the Best Lawyers ranking.